Knowledge is power. Are you facing a new diagnosis or recurrence of Pancreatic Cancer? The GI Connection Pancreatic Cancer Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Pancreatic Cancer. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. Learn more about Pancreatic Cancer.
You are not alone—The GI Connection Community is the leading Social Media Application for individuals seeking information, inspiration, and support. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs. Login or register here.
April 18, 2018
CancerConnect News: The first interim analysis of the SEQUOIA clinical study evaluating the novel immunotherapy drug pegilodecakin in patients with […]
March 5, 2018
CancerConnect News: The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-CTGF antibody, pamrevlumab, for […]
February 28, 2018
CancerConnect News: Clinical data from three ongoing larotrectinib (LOXO-101) clinical trials in patients whose tumors harbor tropomyosin receptor kinase (TRK) […]
August 15, 2017
A new clinical study will investigate napabucasin – an orally administered investigational agent designed to inhibit cancer stemness pathways by […]
July 11, 2017
ARMO BioSciences, Inc., a late-stage immuno-oncology company, announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) at […]
March 2, 2017
Updated results from an ongoing clinical study of pamrevlumab (FG-3019) in combination with standard-of-care chemotherapy in patients with locally advanced […]
February 17, 2017
Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. […]